Mochi Health vs Eden
$278/mo against $298/mo for tirzepatide. Which is worth it, and for whom.
Updated 2026-09-18
How we are paid: one company on this page — Coreage Rx — pays us a commission if you sign up through our link. It does not buy a better score, a higher position, or the removal of a single criticism. Our rating method and full disclosure are both public.
Both sell tirzepatide. Mochi Health costs $278 a month and Eden costs $298, a difference of $20 a month or about $240 a year. The other differences matter more than the money if this is your first course.
Mochi Health is insurance concierge support. Eden is low advertised medication price. They are not aimed at the same person, and the cheaper one is not automatically the right answer — particularly if this is your first course and you expect a slow titration.
What this means for your titration. Both price the same way as your dose climbs, so the gap between them stays constant the whole way up the ladder.
Side by side
| Mochi Health | Eden | |
|---|---|---|
| Advertised from | $199 | $199 |
| Membership on top | $79/mo | $99/mo |
| True monthly cost | $278 | $298 |
| Roughly, per year | $3,336 | $3,576 |
| Price includes medication | Yes | Yes |
| Names its pharmacy | Not published | Not published |
| Our score | 3.6 / 5 | 3.1 / 5 |
Prices verified 2026-09-18. "True monthly cost" is what you are billed in month two, once any introductory rate has lapsed and any membership has renewed.
The differences that affect treatment
They differ on 2 of the 7 things we track, and behave the same on the other 5. The differences are what the price gap is actually buying.
| Mochi | Eden | |
|---|---|---|
| Will pursue insurance coverage | Yes | No |
| Can dispense FDA-approved branded medication | Yes | No |
What each programme publishes: Mochi Health
- Membership $79/month, or about $66/month on longer prepaid terms.
- Prepaid terms listed at $199 for three months, $399 for six and $799 for twelve.
- Compounded semaglutide around $99 and tirzepatide around $199 on published dose ranges.
- Some members report $69/month provider access with $175 per 28 days of compounded semaglutide.
- Holds roughly a 4 to 4.5 star Trustpilot average across approximately 18,000 public reviews.
- Lab work, where recommended, is not included in the membership.
Where it wins: The insurance concierge genuinely pursues coverage rather than defaulting to cash pay. Watch for: Labs are billed separately. Ask what the clinic expects to order before you sign up.
What each programme publishes: Eden
- Compounded semaglutide advertised at $99/month.
- Compounded tirzepatide advertised at $199/month.
- Membership is $39 as an introductory rate, then $99/month ongoing.
- True ongoing cost for tirzepatide lands near $298/month once membership is included.
Where it wins: Genuinely low medication-only pricing. Watch for: The $99 semaglutide headline becomes roughly $198/month once the membership renews at its ongoing rate.
Strengths of each
Mochi Health.
- The insurance concierge genuinely pursues coverage rather than defaulting to cash pay.
- Large, public review base rather than a handful of curated quotes.
- Prepaid terms meaningfully reduce the membership cost.
Eden.
- Genuinely low medication-only pricing.
- Fast onboarding with flat rates across published dose ranges.
How they score
| What we weigh | Weight | Mochi | Eden |
|---|---|---|---|
| True monthly cost | 30% | 3.3 | 3.1 |
| Price honesty | 20% | 3.4 | 2.6 |
| Clinical support | 20% | 4.2 | 3.3 |
| Pharmacy sourcing | 15% | 3.8 | 3.4 |
| Cancelling | 15% | 3.2 | 3.1 |
Mochi Health scores higher overall at 3.6 out of 5. The weights are published on how we rate, and so is the note about which of these is our paid featured partner.
Which suits you
- Pick Mochi Health if cost is the binding constraint. Over a year the gap is about $240, which is real money for the same class of medication.
- Pick Eden if what it does better matters to you — genuinely low medication-only pricing.
- Ask both which pharmacy compounds the medication and whether it is a 503A or 503B facility. Neither publishes it.
The verdict
For most people starting out, Mochi Health at $278 a month is the more defensible choice on arithmetic alone. Eden earns its premium only if you will actually use what it does differently. Read the full reviews before deciding: Mochi Health and Eden.
How they sit against everyone else
| Programme | Per month | Dose-price | Our score |
|---|---|---|---|
| Coreage Rx Best overall on true monthly cost | $199 | Flat | 4.5 |
| Trimi Lowest flat price with named pharmacies | $125 | Varies | 4.6 |
| PlexusDx Pharmacy transparency and genetic testing | $189 | Varies | 4.4 |
| Ozari Health Lowest advertised semaglutide price | $125 | Varies | 4.4 |
| Fifty 410 Prepaid blocks with no subscription | $133 | Varies | 4.2 |
| Ivím Health Unlimited clinician access | $199 | Varies | 4 |
| Mochi Health Insurance concierge support | $278 incl. $79 fee | Varies | 3.6 |
| Coby Health Multi-month value with supplies included | $239 | Varies | 3.6 |
| Hims & Hers Widest range of formats | $238 incl. $39 fee | Varies | 3.5 |
| Ro Branded medication with insurance help | $448 incl. $149 fee | Varies | 3.5 |
| Zealthy Low-cost entry with insurance routing | $216 | Varies | 3.5 |
| LifeMD Insurance coordination | $149 | Varies | 3.5 |
Read next
- Mochi Health tirzepatide review
Insurance concierge support. How they handle your dose ladder, what support looks like when side effects hit, and what you actually pay — $278 a month.
- Eden tirzepatide review
Low advertised medication price. How they handle your dose ladder, what support looks like when side effects hit, and what you actually pay — $298 a month.
- How to spot a bad seller
The FDA sent more than 55 warning letters to online GLP-1 sellers in one day. Here is how to tell a licensed programme from the rest.
- The twelve-month cost
Month one is the cheapest month you will have. Here is the full-year arithmetic, including the costs nobody puts in the advert.
- Best programmes if this is your first time
Ranked on how they price the dose ladder and how reachable support is — the two things that decide whether a beginner stays on treatment.